Table 1.
Patients characteristics, N = 58.
| Age | 58.8 ± 12.4 (21–73) |
| Sex | |
| Females | 39 (67.2%) |
| Males | 19 (32.8%) |
| Preoperative Creatinine | 0.81 ± 0.27 (0.29–1.50) |
| BMI | 28.76 ± 7.43 (18–49) |
| Comorbiditiesa | |
| Yes | 33 (56.9%) |
| No | 25 (43.1%) |
| PCI | 14.91 ± 9.12 (0–39) |
| CC-0/1 | 48 (82.7%) |
| LOS | 10.47 ± 4.53 [[5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]] |
| Clavien-Dindo Complication | 30 (51.7%) |
| Grade I-II | 17 (29.3%) |
| Grade III-IV | 13 (22.4%) |
| AKI (per KDIGO criteria) | 12 (20.7%) |
| 0–30 days Mortality | 1 (1.7%, cerebral edema) |
| 31–90 days Mortality | 1 (1.7%, GI bleed) |
Results expressed a mean ± standard deviation (range) or n (percentage). BMI = Body Mass index, PCI = peritoneal carcinomatosis index, CC = completeness of cytoreduction, GI = Gastrointestinal, LOS = length of stay, AKI = acute kidney injury, KDIGO= Kidney Disease: Improving Global Outcomes.
a
Comorbidities that affect kidney function in the perioperative period were accounted for, such as the established diagnoses of hypertension, diabetes mellitus, cardiac disease, or systemic autoimmune diseases such as systemic lupus erythematous. Missing variables = none.